A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...

Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ...

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...

Oregon State University scientists have developed a highly efficient, uniquely shaped magnetic nanoparticle that could enable ...

In a study on ovarian cancer cells, researchers from Karolinska Institutet demonstrate how the tumor environment influences ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli ...

The study, published in JAMA Network Open, looked at more than 200,000 women with ovarian cancer who took a test called CA-125. This test checks for a tumor marker in the blood that can be a sign of ...

Finding ovarian cancer early can lead to better chances ... The test measures a tumor marker in the blood, and doctors use it to determine if a woman with a suspicious lump should be referred ...